Loading...
Market
Will BEYFORTUS® receive approval from the EMA by June 30, 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
European Medicines Agency (EMA) official announcements
Story
Sanofi and AstraZeneca Win FDA Approval for BEYFORTUS® Manufacturing Line to Protect Babies
Sep 16, 2024, 05:00 PM
Sanofi and AstraZeneca have received approval from the U.S. Food and Drug Administration (FDA) for a manufacturing line dedicated to their preventive respiratory syncytial virus (RSV) therapy. The approval allows Sanofi to begin shipping BEYFORTUS® in the United States, aimed at protecting babies against RSV disease. This development marks a significant step for both companies in their efforts to combat RSV.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
